By Emeritus Professor Andrew Lloyd

Journal articles

Carson JM; Barbieri S; Verich A; Tu E; Lloyd A; Dore GJ; Matthews GV; Martinello M, 2026, 'Development of a Machine Learning Model to Predict Short Duration HCV Treatment Response', Journal of Viral Hepatitis, 33, pp. e70229, http://dx.doi.org/10.1111/jvh.70229

Kronfli N; Popovic N; Weiss E; Stoové M; Lafferty L; Price O; Madden LM; Hajarizadeh B; Lloyd AR; Altice FL, 2026, 'Gatekeeping harm reduction in Canadian Federal Prisons: Perspectives on the threat risk assessment for the prison needle exchange program by prison administrative leadership', Addiction, 121, pp. 2091 - 2103, http://dx.doi.org/10.1111/add.70376

Sheehan Y; Garg A; Sheehan J; Maduka N; Altice FL; Alves da Costa F; Cox S; Elsharkawy AM; Salah E; Stoové M; Tavoschi L; Thompson AJ; Thornton K; Lloyd AR; Cabezas J; Akiyama MJ; Kronfli N, 2026, 'Best practice guidelines for viral hepatitis service delivery in prisons', Lancet Infectious Diseases, 26, pp. e302 - e314, http://dx.doi.org/10.1016/S1473-3099(25)00630-9

Maduranga S; Valencia BM; Sigera C; Weeratunga P; Fernando D; Rajapakse S; Lloyd AR; Bull RA; Stone H; Rodrigo C, 2026, 'DENcode: A model for haplotype-informed transmission probability of dengue virus', Plos One, 22, http://dx.doi.org/10.1371/journal.pcbi.1014316

Condé A; Maillard O; Rodrigo C; Bertolotti A; Sandler CX; Lloyd AR; Gérardin P, 2026, 'Post-Infectious Fatigue and Depression Following Dengue: A Systematic Review and Meta-Analysis of Associated Factors', Reviews in Medical Virology, 36, http://dx.doi.org/10.1002/rmv.70164

Conway A; Grebely J; Tillakeratne S; Cunningham EB; Munyengeterwa U; Van Dyk J; Martinello M; Carson J; Lafferty L; Bull RA; Horsburgh B; McGrath C; Brown T; Treloar C; Amin J; Degenhardt L; Applegate TL; Dunlop A; Matthews GV; Dore GJ; Lloyd AR; Hajarizadeh B, 2026, 'Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study', International Journal of Drug Policy, 151, http://dx.doi.org/10.1016/j.drugpo.2026.105234

Lafferty L; Popovic N; Weiss E; Hajarizadeh B; Lloyd AR; Altice FL; Kronfli N, 2026, 'Navigating harm reduction and security mandates: Prison leadership perspectives on implementing prison needle exchange programs in Canada', International Journal of Drug Policy, 150, http://dx.doi.org/10.1016/j.drugpo.2026.105197

Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Roth M; Willing AR; Sazzad HMS; Marshall AD; Fontaine G; Conway A; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Lafferty L; Lloyd A; Sheehan Y; Akiyama MJ; Kronfli N; Cabezas J; Grebely J, 2026, 'Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis', International Journal of Drug Policy, 149, http://dx.doi.org/10.1016/j.drugpo.2025.105082

Maduranga S; Valencia BM; Sigera C; Weeratunga P; Fernando D; Rajapakse S; Rapadas M; Deveson IW; Lloyd AR; Bull R; Rodrigo C, 2026, 'Between- and within-host mutation of dengue virus', Virology, 615, http://dx.doi.org/10.1016/j.virol.2025.110750

Richardson A; Corley S; Delic N; Li H; Lloyd A; Di Girolamo N, 2026, 'Single-Cell RNA Sequencing of Murine Limbal Epithelia Reveals Gas1 as a Novel Stem/Progenitor Cell Marker for the Corneal Epithelium', Cornea, 45, pp. 209 - 222, http://dx.doi.org/10.1097/ICO.0000000000003938

Wijaya R; Stoddart J; Adhikari A; Abayasingam A; Bartlett AW; Rawlinson W; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Martinello M; Lloyd AR; Tedla N; Bull RA; Walker MR, 2026, 'C3d Complement Activation and Antibody Immunity in Convalescent COVID-19: Insights From Adults and Children', Journal of Immunology Research, 2026, http://dx.doi.org/10.1155/jimr/7429749

Zhao Y; Samir J; Keoshkerian E; Li H; An H; Bull RA; Luciani F; Lloyd AR, 2026, 'Progenitor effects and unique transcriptomic signatures linked to differentiation phenotype in clonally expanded antigen-specific CD8 T memory stem cells', Journal of Immunology, 215, http://dx.doi.org/10.1093/jimmun/vkaf299

Horsburgh BA; Abayasingam A; Jenkins F; Li H; Foster CSP; Lloyd A; Coin L; Rawlinson W; Kelleher AD; van Hal S; Bull RA; Di Giallonardo F; Stephenson R; Williams R; Cunningham P; Turra M; Douglas MW; Leong L; McNally LP; Caly L; Dragasevich L; Jackson K; Farrell J; Kok J; Taiaroa G; Williams E; Chibo D; Dwyer D; Rodrigo C; Sevendal A; Castley A, 2025, 'Development and verification of a novel tiling PCR method for long-range HIV-1 sequencing in a diagnostic setting', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-03190-6

Zhao Y; Keoshkerian E; Li H; Sacks-David R; Boo I; Dietze P; Hellard M; Drummer H; Luciani F; Bull RA; Lloyd AR, 2025, 'Functional Antigen-Specific CD8 TSCM Responses Are Associated with Repeated Clearance of Hepatitis C Virus Infection', European Journal of Immunology, 55, http://dx.doi.org/10.1002/eji.70098

Rothhaar P; Arand T; Seong HGT; Heuss C; Tulessin M; Wang Z; Förster C; Schneider AC; Quistrebert J; Chai H; Reineke M; Benning L; Honegger J; Hofmann M; Thimme R; Timm J; Walker AS; Barnes EJ; Hudson F; Dennis E; Smith D; Nguyen D; Halford R; McPherson S; Forton D; Wiselka M; Stone B; Ch’ng CL; Nelson M; Bhagani S; Ala A; Barclay ST; Collier JD; Ryder SD; Verma S; Gilson R; Jones C; McCabe L; Pett S; Cooke GS; Schnitzler P; Merle U; Shoukry NH; Bruneau J; Rodrigo C; Lloyd A; Bull RA; Ansari MA; Mogler C; McLauchlan J; Forns X; Pérez-del-Pulgar S; Lohmann V, 2025, 'Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease', Nature Communications, 16, http://dx.doi.org/10.1038/s41467-025-67174-w

Montague C; Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2025, 'Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep study', International Journal of Drug Policy, 146, http://dx.doi.org/10.1016/j.drugpo.2025.105035

Kronfli N; Lafferty L; Leone F; Stoové M; Hajarizadeh B; Lloyd AR; Altice FL, 2025, 'Using the socioecological model to guide service delivery improvements to the prison needle exchange program in Canada: insights from multi-level stakeholders', BMC Public Health, 25, http://dx.doi.org/10.1186/s12889-025-24935-y

Raijmakers RPH; Lund Berven L; Keijmel SP; Rodrigo C; Wyller VBB; Katz BZ; Buchwald D; Evans RA; Gérardin P; Knoop H; Prins M; Stavem K; Stiansen-Sonerud T; Taylor R; Valencia Arroyo BM; Wensaas KA; Selvakumar JP; van den Wijngaard C; Lloyd AR; Sandler CX, 2025, 'Immunological associations in post-infective fatigue syndromes including Long COVID—a systematic review and meta-analysis', Ebiomedicine, 121, http://dx.doi.org/10.1016/j.ebiom.2025.105970

Bah R; Sheehan Y; Li X; Price N; Butler T; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2025, 'Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons', International Journal of Drug Policy, 144, http://dx.doi.org/10.1016/j.drugpo.2024.104401

Harrison F; Mortby ME; Lloyd AR; Guastella AJ; Trollor JN; Sachdev PS; Brodaty H, 2025, 'Apathy is distinct from depression or fatigue and is associated with poor physical health in an older community cohort', International Psychogeriatrics, 37, http://dx.doi.org/10.1016/j.inpsyc.2025.100089

Ang J; Hajarizadeh B; Tillakeratne S; Dore GJ; Treloar C; Amin J; van Dyk J; Degenhardt L; Applegate T; Dunlop A; Fraser C; Conway B; Wong A; Fuchs D; Powis J; Mason K; Gane EJ; Weltman M; Read P; Martinello M; Rowe E; Baker DA; Wade A; Matthews G; Lafferty L; Lloyd A; Grebely J; Cunningham EB, 2025, 'Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104859

Walker MR; Leung P; Keoshkerian E; Pirozyan MR; Lloyd A; Luciani F; Bull RA, 2025, 'Temporal dynamics of viral fitness and the adaptive immune response in HCV infection', , 13, pp. rp102232, http://dx.doi.org/10.7554/elife.102232

Walker MR; Leung P; Keoshkerian E; Pirozyan MR; Lloyd A; Luciani F; Bull RA, 2025, 'Temporal dynamics of viral fitness and the adaptive immune response in HCV infection', , 13, http://dx.doi.org/10.7554/elife.102232.3

Lafferty L; Brown T; McGrath C; Wright T; Henderson C; Lloyd AR; Grebely J; Treloar C, 2025, 'Implications of the fragility of opioid agonist treatment continuity on hepatitis C re-exposure concerns among people in prison: a qualitative study', International Journal of Drug Policy, 142, pp. 104831 - 104831, http://dx.doi.org/10.1016/j.drugpo.2025.104831

Legrand NM; Bull RA; Hajarizadeh B; Lloyd AR; Johnston K; Issa K; Harvey C; Arnott A; Dwyer DE; Sintchenko V; Grant L; Dore GJ; Kaldor J; Martinello M, 2025, 'Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia', Emerging Infectious Diseases, 31, pp. 1527 - 1536, http://dx.doi.org/10.3201/eid3108.240571

Kabir KMA; Sigera C; Maduranga S; Weeratunga P; Rajapakse S; Fernando D; Lloyd AR; Bull RA; Rodrigo C, 2025, 'Chikungunya masquerading as dengue infection in Sri Lanka uncovered by metagenomics', Plos One, 20, http://dx.doi.org/10.1371/journal.pone.0326995

Jamali E; Quadeer AA; Tedla N; McKay MR; Lloyd A; Walker MR; Bull RA, 2025, 'Anti-HCV antibodies: A battle for breadth and potency', Antiviral Research, 238, http://dx.doi.org/10.1016/j.antiviral.2025.106165

Tonini E; Crouse JJ; Shin M; Carpenter JS; Lloyd AR; Hindmarsh G; McKenna S; Nichles A; Zmicerevska N; Scott J; Iorfino F; Pantelis C; Nelson B; McGorry PD; Wood SJ; Yung AR; Purcell R; Hickie IB, 2025, 'Multidimensional outcomes associated with chronic fatigue over 12 months in youth with emerging mood disorders', Journal of Psychosomatic Research, 193, http://dx.doi.org/10.1016/j.jpsychores.2025.112141

Kiziloz S; Ward EJ; Hawthorne D; Sinha A; Cooksley G; Sarker D; Crua C; Lloyd A; Shuck CE; Gogotsi Y; Sandeman S, 2025, 'Ti 3 C 2 T x MXene augments osmo-adaptive repression of the inflammatory stress response for improved wound repair', Nanoscale, 17, pp. 12758 - 12774, http://dx.doi.org/10.1039/d4nr04622f

Sazzad HMS; Li H; Hajarizadeh B; Horsburgh BA; Grebely J; Dore GJ; Bull RA; Lloyd AR; Rodrigo C, 2025, 'Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics', Virus Research, 355, http://dx.doi.org/10.1016/j.virusres.2025.199566

Maduranga S; Shrestha LB; Valencia BM; Horton G; Guppy M; Gidding HF; Graves S; Stenos J; Rawlinson W; Lloyd AR; Rodrigo C, 2025, 'Diagnosing and Preventing Q Fever in Regional New South Wales, Australia—A Qualitative Exploration of Perspectives of General Practitioners', Australian Journal of Rural Health, 33, http://dx.doi.org/10.1111/ajr.70030

Li V; McKay FC; Tscharke DC; Smith C; Khanna R; Lechner-Scott J; Rawlinson WD; Lloyd AR; Taylor BV; Morahan JM; Steinman L; Giovannoni G; Bar-Or A; Levy M; Drosu N; Potter A; Caswell N; Smith L; Brady EC; Frost B; Hodgkinson S; Hardy TA; Broadley SA, 2025, 'Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach', CNS Drugs, 39, pp. 305 - 320, http://dx.doi.org/10.1007/s40263-024-01153-5

Moallemi S; Tedla N; Sigera C; Weeratunga P; Fernando D; Rajapakse S; Lloyd AR; Rodrigo C, 2025, 'Early circulating biomarkers to predict plasma leakage in dengue fever', Journal of Infection, 90, http://dx.doi.org/10.1016/j.jinf.2024.106401

Gervais A; Bastard P; Bizien L; Delifer C; Tiberghien P; Rodrigo C; Trespidi F; Angelini M; Rossini G; Lazzarotto T; Conti F; Cassaniti I; Baldanti F; Rovida F; Ferrari A; Mileto D; Mancon A; Abel L; Puel A; Cobat A; Rice CM; Cadar D; Schmidt-Chanasit J; Scheid JF; Lemieux JE; Rosenberg ES; Agudelo M; Tangye SG; Borghesi A; Durand GA; Duburcq-Gury E; Valencia BM; Lloyd AR; Nagy A; Macdonald MM; Simonin Y; Zhang SY; Casanova JL, 2024, 'Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease', Journal of Experimental Medicine, 221, http://dx.doi.org/10.1084/jem.20240942

Shrestha LB; Tungatt K; Aggarwal A; Stubis A; Fewings NL; Fichter C; Akerman A; Rodrigo C; Tedla N; Lee S; Lloyd AR; Brilot F; Britton WJ; Kelleher A; Caterson ID; Douglas MW; Rockett R; Tangye SG; Triccas JA; Turville SG; Sandgren KJ; Bull RA; Cunningham AL; Sorrell T; Maclean M; Camilleri J; Douglas M; Song Y; Mao L; Phu A; Sigmund A; Beard S; Hunt S; Vande More AM; Kandasamy R; Kok J; Byrne J; Lloyd A; Tangye S; O'Sullivan M; Steain M; Baird S; Phetsouphanh C; Zhao Y, 2024, 'Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants', Ebiomedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105461

Walker SJ; Dawson O; Sheehan Y; Shrestha LB; Lloyd AR; Sheehan J; Maduka N; Cabezas J; Kronfli N; Akiyama MJ, 2024, 'Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework', International Journal of Drug Policy, 134, http://dx.doi.org/10.1016/j.drugpo.2024.104628

Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B; Bah R; Li C; Byrne M; Butler T; Musarurwa B; Hooshmand E; Simpson A; Alrayyani M; Price N; Groom M, 2024, 'Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study', Lancet Regional Health Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101240

Ryan H; Dore GJ; Grebely J; Byrne M; Cunningham EB; Martinello M; Lloyd AR; Hajarizadeh B, 2024, 'Hepatitis C treatment outcome among people in prison: The SToP-C study', Liver International, 44, pp. 2996 - 3007, http://dx.doi.org/10.1111/liv.16074

Nibau C; Evans A; King H; Phillips DW; Lloyd A, 2024, 'Homoeologous crossovers are distally biased and underlie genomic instability in first-generation neo-allopolyploid Arabidopsis suecica', New Phytologist, 244, pp. 1315 - 1327, http://dx.doi.org/10.1111/nph.20095

Horsburgh BA; Walker GJ; Kelleher A; Lloyd AR; Bull RA; Giallonardo FD, 2024, 'Next-Generation Sequencing Methods for Near-Real-Time Molecular Epidemiology of HIV and HCV', Reviews in Medical Virology, 34, http://dx.doi.org/10.1002/rmv.70001

Underwood AP; Gupta M; Wu BR; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport MP; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2024, 'B-cell characteristics define HCV reinfection outcome', Journal of Hepatology, 81, pp. 415 - 428, http://dx.doi.org/10.1016/j.jhep.2024.04.004

Lafferty L; Altice FL; Leone F; Stoové M; Lloyd AR; Hajarizadeh B; Kronfli N, 2024, 'Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake', International Journal of Drug Policy, 131, http://dx.doi.org/10.1016/j.drugpo.2024.104549

Rodrigo C; Walker G; Sevendal ATK; Nguyen C; Stelzer-Braid S; Rawlinson W; Graves S; Gidding HF; Stenos J; Lloyd AR, 2024, 'Acute Q fever in patients with an influenza-like illness in regional New South Wales, Australia', Plos Neglected Tropical Diseases, 18, http://dx.doi.org/10.1371/journal.pntd.0012385

Cai C; Keoshkerian E; Wing K; Samir J; Effenberger M; Schober K; Bull RA; Lloyd AR; Busch DH; Luciani F, 2024, 'Discovery of a monoclonal, high-affinity CD8+ T-cell clone following natural hepatitis C virus infection', Immunology and Cell Biology, 102, pp. 630 - 641, http://dx.doi.org/10.1111/imcb.12791

Sheehan Y; Cochrane A; Treloar C; Grebely J; Tedla N; Lloyd AR; Lafferty L, 2024, 'Understanding hepatitis C virus (HCV) health literacy and educational needs among people in prison to enhance HCV care in prisons', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104516

Kronfli N; Lafferty L; Leone F; Stoové M; Hajarizadeh B; Lloyd AR; Altice FL, 2024, 'Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104540

Griffin S; Lee Wilkinson A; Winter R; Hajarizadeh B; MacIsaac M; Papaluca T; Holmes J; Lloyd AR; Carson J; Craigie A; Hellard M; Stoové M; Thompson A, 2024, 'Contribution of prison-based hepatitis C treatment initiations to overall treatment uptake in Victoria, Australia', Lancet Regional Health Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101139

Sheehan Y; Lafferty L; Tedla N; Byrne M; Dawson O; Stewart S; Leber B; Habraken N; Lloyd AR, 2024, 'Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd)', International Journal of Drug Policy, 129, http://dx.doi.org/10.1016/j.drugpo.2024.104461

Tavoschi L; Cocco N; Alves da Costa F; Lloyd AR; Kinner SA, 2024, 'People living in prison must be included in country monitoring systems to accurately assess HCV elimination progress', Lancet Gastroenterology and Hepatology, 9, pp. 500 - 501, http://dx.doi.org/10.1016/S2468-1253(24)00075-X

Bretaña NA; Kwon JA; Grant L; Galouzis J; McGrath C; Hoey W; Blogg J; Lloyd AR; Gray RT, 2024, 'Controlling COVID-19 outbreaks in the correctional setting: A mathematical modelling study', Plos One, 19, http://dx.doi.org/10.1371/journal.pone.0303062

Back to profile page